Imageens Partners with Novartis to Enhance Data 42 Program

Imageens is proud to announce its strategic partnership with Novartis, the global pioneer in the healthcare and pharmaceutical industry. The collaboration marks a significant step towards advancing Novartis’ Data 42 program, through LABEL software.

Novartis’ Data 42 program, aimed at accelerating drug discovery and development through the integration of diverse data sources, is set to receive a powerful boost through this partnership. Imageens’ revolutionary software solution, LABEL, will play a pivotal role in implementing a large-scale data pipeline for the management of DICOM (Digital Imaging and Communications in Medicine) data.

By combining LABEL technology with Novartis’ deep understanding of pharmaceutical research and healthcare, the partnership aims to enhance the extraction, normalization, validation, and transformation processes for medical imaging data. This integration will facilitate seamless data flow and comprehensive analysis. By leveraging the capabilities of LABEL, Novartis aims to enhance their understanding of medical imaging data and speed up harnessing insights for transformative healthcare solutions.